Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Meningioma | 25 | 2023 | 1217 | 4.780 |
Why?
|
Meningeal Neoplasms | 22 | 2023 | 1247 | 4.240 |
Why?
|
Glioma | 36 | 2023 | 3418 | 3.060 |
Why?
|
Brain Neoplasms | 44 | 2023 | 8981 | 2.390 |
Why?
|
Neurosurgical Procedures | 7 | 2019 | 2055 | 0.870 |
Why?
|
Radiography, Dental | 2 | 2012 | 54 | 0.830 |
Why?
|
Carcinoma, Intraductal, Noninfiltrating | 7 | 2005 | 936 | 0.780 |
Why?
|
Aneurysm, Ruptured | 2 | 2018 | 459 | 0.690 |
Why?
|
Breast Neoplasms | 30 | 2017 | 21017 | 0.660 |
Why?
|
Neoplasms, Radiation-Induced | 2 | 2012 | 546 | 0.620 |
Why?
|
Isocitrate Dehydrogenase | 3 | 2023 | 929 | 0.620 |
Why?
|
Intracranial Aneurysm | 4 | 2023 | 1276 | 0.610 |
Why?
|
Radiosurgery | 7 | 2019 | 1342 | 0.590 |
Why?
|
Chromosomes, Human, Pair 11 | 1 | 2018 | 410 | 0.580 |
Why?
|
Case-Control Studies | 30 | 2023 | 22031 | 0.570 |
Why?
|
Polymorphism, Single Nucleotide | 14 | 2019 | 15773 | 0.530 |
Why?
|
Craniotomy | 5 | 2017 | 741 | 0.500 |
Why?
|
Estrogen Replacement Therapy | 3 | 2012 | 1206 | 0.500 |
Why?
|
Carcinoma in Situ | 3 | 2012 | 796 | 0.480 |
Why?
|
Soybean Proteins | 1 | 2014 | 55 | 0.450 |
Why?
|
Connecticut | 8 | 2017 | 365 | 0.450 |
Why?
|
Genetic Predisposition to Disease | 21 | 2023 | 17768 | 0.440 |
Why?
|
Central Nervous System Neoplasms | 4 | 2022 | 916 | 0.430 |
Why?
|
Embolization, Therapeutic | 2 | 2023 | 1407 | 0.420 |
Why?
|
Family Health | 5 | 2013 | 1256 | 0.410 |
Why?
|
Molecular Targeted Therapy | 2 | 2023 | 2796 | 0.410 |
Why?
|
Receptors, Progesterone | 5 | 2022 | 1130 | 0.410 |
Why?
|
Carcinoma, Ductal, Breast | 3 | 2012 | 1096 | 0.390 |
Why?
|
Reproductive History | 1 | 2012 | 211 | 0.380 |
Why?
|
Spinal Cord Neoplasms | 2 | 2012 | 263 | 0.380 |
Why?
|
Genome-Wide Association Study | 13 | 2019 | 12604 | 0.380 |
Why?
|
Spinal Fusion | 2 | 2011 | 1280 | 0.370 |
Why?
|
Middle Aged | 76 | 2023 | 219560 | 0.370 |
Why?
|
Leukocytes | 1 | 2019 | 2025 | 0.360 |
Why?
|
Genes, BRCA1 | 3 | 2005 | 765 | 0.350 |
Why?
|
Genetic Loci | 2 | 2019 | 2612 | 0.350 |
Why?
|
Lymphoma, AIDS-Related | 1 | 2010 | 79 | 0.340 |
Why?
|
Models, Genetic | 7 | 2019 | 3441 | 0.340 |
Why?
|
Evolution, Molecular | 1 | 2018 | 1885 | 0.340 |
Why?
|
Female | 96 | 2023 | 390316 | 0.330 |
Why?
|
Adult | 71 | 2023 | 219916 | 0.330 |
Why?
|
Body Mass Index | 7 | 2019 | 12876 | 0.320 |
Why?
|
Carcinoma, Lobular | 2 | 2003 | 489 | 0.320 |
Why?
|
Humans | 129 | 2023 | 758381 | 0.320 |
Why?
|
Aged | 58 | 2019 | 168217 | 0.310 |
Why?
|
Risk Factors | 45 | 2020 | 73806 | 0.310 |
Why?
|
Smoking | 4 | 2012 | 9042 | 0.300 |
Why?
|
Bone Morphogenetic Proteins | 2 | 2011 | 841 | 0.300 |
Why?
|
Lumbar Vertebrae | 3 | 2012 | 1868 | 0.300 |
Why?
|
Medical History Taking | 1 | 2011 | 772 | 0.290 |
Why?
|
Salvage Therapy | 5 | 2018 | 1268 | 0.280 |
Why?
|
Spinal Diseases | 1 | 2011 | 559 | 0.270 |
Why?
|
Contraceptives, Oral | 2 | 2012 | 554 | 0.270 |
Why?
|
Hospital Mortality | 2 | 2018 | 5273 | 0.270 |
Why?
|
Hypersensitivity | 3 | 2016 | 1155 | 0.270 |
Why?
|
Male | 63 | 2023 | 358742 | 0.270 |
Why?
|
Mendelian Randomization Analysis | 4 | 2020 | 993 | 0.260 |
Why?
|
Contraceptives, Oral, Hormonal | 1 | 2007 | 190 | 0.260 |
Why?
|
Genetic Linkage | 6 | 2018 | 2381 | 0.260 |
Why?
|
Prognosis | 20 | 2022 | 29558 | 0.260 |
Why?
|
Ovarian Neoplasms | 7 | 2003 | 4876 | 0.250 |
Why?
|
Accidental Falls | 5 | 1996 | 1056 | 0.250 |
Why?
|
Neoplasms, Hormone-Dependent | 1 | 2008 | 412 | 0.250 |
Why?
|
Oncogenes | 3 | 1996 | 1221 | 0.240 |
Why?
|
Immunoglobulin E | 1 | 2011 | 1484 | 0.240 |
Why?
|
Supratentorial Neoplasms | 1 | 2006 | 159 | 0.240 |
Why?
|
Quality of Life | 3 | 2023 | 13286 | 0.240 |
Why?
|
North Carolina | 2 | 2017 | 323 | 0.240 |
Why?
|
Genes, BRCA2 | 2 | 2005 | 603 | 0.240 |
Why?
|
Endovascular Procedures | 1 | 2018 | 2139 | 0.230 |
Why?
|
Spinal Neoplasms | 1 | 2011 | 716 | 0.230 |
Why?
|
Glioblastoma | 5 | 2018 | 3480 | 0.230 |
Why?
|
Breast Feeding | 1 | 2012 | 1355 | 0.230 |
Why?
|
Texas | 2 | 2017 | 402 | 0.230 |
Why?
|
Genotype | 11 | 2019 | 12945 | 0.230 |
Why?
|
Autoantibodies | 1 | 2012 | 2118 | 0.230 |
Why?
|
Risk | 10 | 2019 | 9599 | 0.230 |
Why?
|
Receptors, Estrogen | 6 | 2023 | 2211 | 0.230 |
Why?
|
Length of Stay | 3 | 2018 | 6439 | 0.220 |
Why?
|
Sex Factors | 10 | 2022 | 10505 | 0.220 |
Why?
|
Lymphoma, Non-Hodgkin | 1 | 2010 | 1373 | 0.210 |
Why?
|
Young Adult | 25 | 2018 | 58808 | 0.210 |
Why?
|
Antineoplastic Agents | 2 | 2023 | 13591 | 0.200 |
Why?
|
Reoperation | 4 | 2017 | 4282 | 0.200 |
Why?
|
Neoplasms, Second Primary | 2 | 2015 | 1056 | 0.200 |
Why?
|
Odds Ratio | 9 | 2019 | 9650 | 0.200 |
Why?
|
Disease Management | 1 | 2011 | 2500 | 0.180 |
Why?
|
Mutation | 8 | 2023 | 29915 | 0.170 |
Why?
|
Aneurysm | 1 | 2023 | 336 | 0.170 |
Why?
|
SEER Program | 3 | 2011 | 1530 | 0.170 |
Why?
|
Frail Elderly | 2 | 1996 | 752 | 0.160 |
Why?
|
Survival Rate | 7 | 2019 | 12721 | 0.160 |
Why?
|
Postoperative Complications | 7 | 2017 | 15638 | 0.160 |
Why?
|
Chromosomes, Human, Pair 17 | 3 | 2015 | 419 | 0.160 |
Why?
|
Receptor, erbB-2 | 5 | 2017 | 2553 | 0.160 |
Why?
|
Follow-Up Studies | 14 | 2023 | 39060 | 0.160 |
Why?
|
Treatment Outcome | 18 | 2023 | 64379 | 0.160 |
Why?
|
United States | 17 | 2018 | 72140 | 0.150 |
Why?
|
Activities of Daily Living | 5 | 2017 | 2414 | 0.150 |
Why?
|
Aged, 80 and over | 23 | 2019 | 58681 | 0.150 |
Why?
|
Age Factors | 14 | 2018 | 18357 | 0.140 |
Why?
|
Germ-Line Mutation | 3 | 2014 | 1840 | 0.140 |
Why?
|
Risk Assessment | 9 | 2019 | 23883 | 0.140 |
Why?
|
Neoplasm Recurrence, Local | 5 | 2022 | 9273 | 0.140 |
Why?
|
Informed Consent | 1 | 2023 | 1003 | 0.130 |
Why?
|
Gene Expression Regulation, Neoplastic | 4 | 2019 | 8506 | 0.130 |
Why?
|
Calcifediol | 1 | 2017 | 161 | 0.130 |
Why?
|
Family | 4 | 2015 | 3188 | 0.130 |
Why?
|
Epidemiologic Methods | 1 | 2000 | 1338 | 0.130 |
Why?
|
Linkage Disequilibrium | 2 | 2018 | 1996 | 0.130 |
Why?
|
Chickenpox | 1 | 2016 | 97 | 0.130 |
Why?
|
Pedigree | 9 | 2015 | 4578 | 0.120 |
Why?
|
Proportional Hazards Models | 8 | 2017 | 12440 | 0.120 |
Why?
|
Heterozygote | 2 | 1998 | 2797 | 0.120 |
Why?
|
Registries | 7 | 2017 | 8176 | 0.120 |
Why?
|
Quality Improvement | 4 | 2017 | 3806 | 0.120 |
Why?
|
Genes, Tumor Suppressor | 1 | 1998 | 1055 | 0.120 |
Why?
|
Biomedical Research | 1 | 2010 | 3417 | 0.120 |
Why?
|
Mammography | 4 | 2008 | 2427 | 0.120 |
Why?
|
Telomere-Binding Proteins | 1 | 2014 | 119 | 0.110 |
Why?
|
Socioeconomic Factors | 3 | 2012 | 7817 | 0.110 |
Why?
|
MutS Homolog 2 Protein | 1 | 2014 | 195 | 0.110 |
Why?
|
Molecular Epidemiology | 1 | 2015 | 469 | 0.110 |
Why?
|
California | 1 | 2017 | 1419 | 0.110 |
Why?
|
Radiotherapy, Adjuvant | 2 | 2019 | 1791 | 0.110 |
Why?
|
Morpholines | 1 | 2016 | 580 | 0.110 |
Why?
|
Adolescent | 20 | 2018 | 87888 | 0.110 |
Why?
|
Serum Albumin | 1 | 2016 | 673 | 0.110 |
Why?
|
Incidence | 10 | 2017 | 21273 | 0.110 |
Why?
|
Nuclear Matrix-Associated Proteins | 1 | 2012 | 38 | 0.110 |
Why?
|
Counseling | 1 | 2001 | 1541 | 0.100 |
Why?
|
Phosphopyruvate Hydratase | 1 | 2012 | 127 | 0.100 |
Why?
|
San Francisco | 1 | 2012 | 162 | 0.100 |
Why?
|
Aminopyridines | 1 | 2016 | 564 | 0.100 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2022 | 2858 | 0.100 |
Why?
|
Antigens, Nuclear | 1 | 2012 | 184 | 0.100 |
Why?
|
Massachusetts | 2 | 2017 | 8823 | 0.100 |
Why?
|
Kaplan-Meier Estimate | 3 | 2011 | 6493 | 0.100 |
Why?
|
Logistic Models | 7 | 2018 | 13276 | 0.100 |
Why?
|
Dacarbazine | 1 | 2015 | 559 | 0.100 |
Why?
|
Cohort Studies | 10 | 2022 | 41252 | 0.100 |
Why?
|
Age of Onset | 3 | 2012 | 3298 | 0.100 |
Why?
|
Dysplastic Nevus Syndrome | 1 | 1992 | 61 | 0.100 |
Why?
|
Retrospective Studies | 18 | 2023 | 80170 | 0.100 |
Why?
|
Melanoma | 3 | 2017 | 5691 | 0.100 |
Why?
|
Health Facility Size | 1 | 2011 | 62 | 0.100 |
Why?
|
Neoplasms | 5 | 2023 | 22030 | 0.100 |
Why?
|
National Cancer Institute (U.S.) | 2 | 2010 | 296 | 0.100 |
Why?
|
Radiation, Ionizing | 1 | 2012 | 251 | 0.090 |
Why?
|
Antineoplastic Agents, Alkylating | 1 | 2015 | 617 | 0.090 |
Why?
|
Medicare Part A | 1 | 2011 | 40 | 0.090 |
Why?
|
Neovascularization, Pathologic | 1 | 2001 | 2638 | 0.090 |
Why?
|
Linear Models | 2 | 2011 | 5861 | 0.090 |
Why?
|
Genes, p16 | 1 | 2010 | 159 | 0.090 |
Why?
|
Eczema | 1 | 2012 | 245 | 0.090 |
Why?
|
Genomics | 3 | 2023 | 5789 | 0.090 |
Why?
|
Nevus | 1 | 1992 | 205 | 0.090 |
Why?
|
Multiprotein Complexes | 1 | 2016 | 1120 | 0.080 |
Why?
|
Menarche | 1 | 2012 | 529 | 0.080 |
Why?
|
Parity | 1 | 2012 | 925 | 0.080 |
Why?
|
Models, Statistical | 2 | 2001 | 5070 | 0.080 |
Why?
|
International Cooperation | 1 | 2015 | 1430 | 0.080 |
Why?
|
Practice Guidelines as Topic | 3 | 2008 | 7377 | 0.080 |
Why?
|
Geography | 1 | 2011 | 659 | 0.080 |
Why?
|
Dental Care | 1 | 2012 | 279 | 0.080 |
Why?
|
Primary Prevention | 1 | 1996 | 1185 | 0.080 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2018 | 2270 | 0.080 |
Why?
|
Surgical Instruments | 1 | 2011 | 385 | 0.080 |
Why?
|
Mental Health | 2 | 2017 | 3232 | 0.080 |
Why?
|
Survival Analysis | 3 | 2017 | 10112 | 0.080 |
Why?
|
Tumor Suppressor Proteins | 2 | 2023 | 2800 | 0.080 |
Why?
|
Neoplastic Syndromes, Hereditary | 1 | 1991 | 243 | 0.080 |
Why?
|
Chromosome Mapping | 4 | 2012 | 4624 | 0.080 |
Why?
|
Patient Discharge | 2 | 2018 | 3433 | 0.080 |
Why?
|
Genes, p53 | 1 | 2010 | 712 | 0.080 |
Why?
|
Thrombocytopenia | 1 | 2016 | 1172 | 0.080 |
Why?
|
Surgical Wound Infection | 1 | 2017 | 1526 | 0.070 |
Why?
|
Attitude to Health | 2 | 2008 | 2025 | 0.070 |
Why?
|
Alleles | 6 | 2018 | 6895 | 0.070 |
Why?
|
Hospital Charges | 1 | 2009 | 357 | 0.070 |
Why?
|
Insurance Claim Review | 1 | 2011 | 737 | 0.070 |
Why?
|
Vitamin D Deficiency | 1 | 2017 | 1377 | 0.070 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2016 | 2057 | 0.070 |
Why?
|
RNA, Small Interfering | 1 | 2016 | 3433 | 0.070 |
Why?
|
Hormones | 1 | 1991 | 869 | 0.070 |
Why?
|
Aspirin | 1 | 2018 | 3132 | 0.070 |
Why?
|
Chromosomes, Human, Pair 22 | 1 | 2008 | 346 | 0.070 |
Why?
|
Neurilemmoma | 1 | 2012 | 523 | 0.070 |
Why?
|
Tumor Burden | 3 | 2019 | 1893 | 0.070 |
Why?
|
Combined Modality Therapy | 3 | 2018 | 8530 | 0.070 |
Why?
|
Receptors, Immunologic | 1 | 2012 | 1411 | 0.070 |
Why?
|
Diffusion of Innovation | 1 | 2011 | 728 | 0.070 |
Why?
|
DNA Copy Number Variations | 1 | 2015 | 2012 | 0.070 |
Why?
|
Wounds and Injuries | 2 | 1995 | 2476 | 0.070 |
Why?
|
Obesity | 2 | 2019 | 12870 | 0.070 |
Why?
|
Legislation as Topic | 1 | 2005 | 77 | 0.060 |
Why?
|
Steroids | 1 | 1991 | 926 | 0.060 |
Why?
|
Genetic Markers | 3 | 2007 | 2608 | 0.060 |
Why?
|
Prospective Studies | 8 | 2019 | 54136 | 0.060 |
Why?
|
Confidence Intervals | 2 | 2016 | 2925 | 0.060 |
Why?
|
Immunohistochemistry | 4 | 2023 | 11070 | 0.060 |
Why?
|
Child, Preschool | 8 | 2017 | 42058 | 0.060 |
Why?
|
Cell Cycle Proteins | 2 | 2016 | 3443 | 0.060 |
Why?
|
Seizures | 1 | 2018 | 2919 | 0.060 |
Why?
|
Longitudinal Studies | 2 | 2018 | 14481 | 0.060 |
Why?
|
Skin Neoplasms | 2 | 2017 | 5797 | 0.060 |
Why?
|
Thoracic Vertebrae | 1 | 2009 | 596 | 0.060 |
Why?
|
Patient Compliance | 2 | 2005 | 2685 | 0.060 |
Why?
|
Diet | 2 | 2020 | 8003 | 0.060 |
Why?
|
Menopause | 1 | 2012 | 1639 | 0.060 |
Why?
|
Rare Diseases | 1 | 2010 | 619 | 0.060 |
Why?
|
Disease-Free Survival | 1 | 2015 | 6821 | 0.060 |
Why?
|
Vitamin D | 1 | 2018 | 3283 | 0.060 |
Why?
|
Disease Progression | 5 | 2019 | 13468 | 0.060 |
Why?
|
Karnofsky Performance Status | 2 | 2015 | 165 | 0.060 |
Why?
|
Health Care Surveys | 1 | 2011 | 2432 | 0.060 |
Why?
|
Multivariate Analysis | 3 | 2015 | 12096 | 0.060 |
Why?
|
HIV Infections | 1 | 2010 | 17275 | 0.060 |
Why?
|
Low Back Pain | 1 | 2012 | 979 | 0.060 |
Why?
|
International Agencies | 2 | 2018 | 243 | 0.050 |
Why?
|
Time Factors | 5 | 2019 | 39873 | 0.050 |
Why?
|
Infant | 6 | 2017 | 36054 | 0.050 |
Why?
|
Diagnostic Tests, Routine | 1 | 2009 | 787 | 0.050 |
Why?
|
Health Status | 4 | 2006 | 4069 | 0.050 |
Why?
|
Drug Utilization | 1 | 2009 | 1187 | 0.050 |
Why?
|
Gene Frequency | 3 | 2012 | 3612 | 0.050 |
Why?
|
Magnetic Resonance Imaging | 5 | 2016 | 36285 | 0.050 |
Why?
|
Cervical Vertebrae | 1 | 2009 | 977 | 0.050 |
Why?
|
HIV | 1 | 2010 | 1581 | 0.050 |
Why?
|
Patient Readmission | 1 | 2017 | 3261 | 0.050 |
Why?
|
Prevalence | 3 | 2014 | 15646 | 0.050 |
Why?
|
Colonic Neoplasms | 1 | 2014 | 2523 | 0.050 |
Why?
|
Hepatic Artery | 1 | 2023 | 230 | 0.050 |
Why?
|
Genetic Variation | 4 | 2019 | 6548 | 0.050 |
Why?
|
Lod Score | 2 | 2012 | 602 | 0.050 |
Why?
|
DNA-Binding Proteins | 2 | 2023 | 9575 | 0.050 |
Why?
|
Infant, Newborn | 3 | 2017 | 26182 | 0.050 |
Why?
|
Genome, Human | 2 | 2011 | 4415 | 0.050 |
Why?
|
Mass Screening | 3 | 2008 | 5425 | 0.050 |
Why?
|
Gene Expression Profiling | 3 | 2016 | 9405 | 0.050 |
Why?
|
Somatostatin | 1 | 2022 | 447 | 0.050 |
Why?
|
Genes, Dominant | 3 | 1994 | 862 | 0.050 |
Why?
|
Neoplasm Staging | 2 | 2006 | 11152 | 0.040 |
Why?
|
Intracranial Hemorrhages | 2 | 2016 | 820 | 0.040 |
Why?
|
Skull Base | 1 | 2023 | 291 | 0.040 |
Why?
|
Apoptosis | 1 | 2016 | 9468 | 0.040 |
Why?
|
Age Distribution | 1 | 2006 | 2882 | 0.040 |
Why?
|
Cost-Benefit Analysis | 2 | 2011 | 5484 | 0.040 |
Why?
|
Quantitative Trait Loci | 2 | 2019 | 2100 | 0.040 |
Why?
|
Chromosomes, Human, Pair 3 | 2 | 2018 | 315 | 0.040 |
Why?
|
Child | 8 | 2017 | 79813 | 0.040 |
Why?
|
Statistics, Nonparametric | 1 | 2005 | 2850 | 0.040 |
Why?
|
Gonadal Steroid Hormones | 1 | 2023 | 701 | 0.040 |
Why?
|
Propensity Score | 2 | 2017 | 1907 | 0.040 |
Why?
|
Metabolism | 1 | 2020 | 193 | 0.040 |
Why?
|
Chromosomes, Human, Pair 19 | 1 | 2019 | 347 | 0.040 |
Why?
|
Monitoring, Intraoperative | 1 | 2005 | 939 | 0.040 |
Why?
|
Progesterone | 1 | 2022 | 742 | 0.040 |
Why?
|
Faculty, Medical | 1 | 1987 | 1192 | 0.040 |
Why?
|
Calcium-Binding Proteins | 1 | 2023 | 1066 | 0.040 |
Why?
|
Israel | 2 | 2013 | 721 | 0.040 |
Why?
|
Chromosomes, Human, Pair 1 | 1 | 2019 | 635 | 0.040 |
Why?
|
Chromosomes, Human, Pair 7 | 1 | 2018 | 310 | 0.040 |
Why?
|
Necrosis | 1 | 2001 | 1604 | 0.030 |
Why?
|
Signal Transduction | 2 | 2019 | 23341 | 0.030 |
Why?
|
Waist-Hip Ratio | 1 | 2018 | 516 | 0.030 |
Why?
|
Body Constitution | 1 | 1997 | 273 | 0.030 |
Why?
|
Environmental Exposure | 1 | 2011 | 4411 | 0.030 |
Why?
|
Chromosomes, Human, Pair 8 | 1 | 2018 | 452 | 0.030 |
Why?
|
Eukaryotic Initiation Factors | 1 | 2016 | 86 | 0.030 |
Why?
|
Life Tables | 1 | 1996 | 365 | 0.030 |
Why?
|
World Health Organization | 1 | 2022 | 1312 | 0.030 |
Why?
|
Educational Status | 1 | 2023 | 2513 | 0.030 |
Why?
|
Hospitalization | 1 | 2015 | 10653 | 0.030 |
Why?
|
Postural Balance | 2 | 1996 | 617 | 0.030 |
Why?
|
Aging | 2 | 1992 | 8651 | 0.030 |
Why?
|
Adaptor Proteins, Signal Transducing | 2 | 2016 | 2895 | 0.030 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p15 | 1 | 2014 | 70 | 0.030 |
Why?
|
Ki-67 Antigen | 1 | 2016 | 631 | 0.030 |
Why?
|
Fibrosis | 1 | 2001 | 2038 | 0.030 |
Why?
|
Tumor Suppressor Protein p53 | 2 | 2015 | 2912 | 0.030 |
Why?
|
Caspase 3 | 1 | 2016 | 728 | 0.030 |
Why?
|
New England | 1 | 2017 | 1053 | 0.030 |
Why?
|
Preoperative Period | 1 | 2016 | 553 | 0.030 |
Why?
|
Comparative Genomic Hybridization | 1 | 2015 | 473 | 0.030 |
Why?
|
Telomerase | 1 | 2019 | 745 | 0.030 |
Why?
|
Treatment Failure | 1 | 2019 | 2640 | 0.030 |
Why?
|
Platelet Count | 1 | 2016 | 775 | 0.030 |
Why?
|
Selection Bias | 1 | 2015 | 357 | 0.030 |
Why?
|
Motivation | 1 | 2023 | 1996 | 0.030 |
Why?
|
Oligodendroglioma | 1 | 2014 | 279 | 0.030 |
Why?
|
Neoplasm Invasiveness | 1 | 2001 | 3617 | 0.030 |
Why?
|
Diseases in Twins | 1 | 1995 | 447 | 0.030 |
Why?
|
Cranial Irradiation | 1 | 2015 | 390 | 0.030 |
Why?
|
Internationality | 1 | 2018 | 1000 | 0.030 |
Why?
|
Calcinosis | 1 | 2001 | 1467 | 0.030 |
Why?
|
Neoplasm Transplantation | 1 | 2016 | 2013 | 0.030 |
Why?
|
Health Services for the Aged | 1 | 1994 | 259 | 0.020 |
Why?
|
Meta-Analysis as Topic | 1 | 2017 | 1373 | 0.020 |
Why?
|
Genomic Instability | 1 | 2016 | 704 | 0.020 |
Why?
|
Subarachnoid Hemorrhage | 1 | 2000 | 1031 | 0.020 |
Why?
|
Likelihood Functions | 2 | 2012 | 987 | 0.020 |
Why?
|
Nuclear Family | 1 | 1993 | 313 | 0.020 |
Why?
|
Geriatric Assessment | 2 | 1996 | 1404 | 0.020 |
Why?
|
Hematoma | 1 | 2016 | 768 | 0.020 |
Why?
|
Colorectal Neoplasms, Hereditary Nonpolyposis | 1 | 1995 | 380 | 0.020 |
Why?
|
Clinical Trials as Topic | 1 | 2007 | 7985 | 0.020 |
Why?
|
BRCA2 Protein | 1 | 1996 | 798 | 0.020 |
Why?
|
Laminectomy | 1 | 2012 | 224 | 0.020 |
Why?
|
Craniocerebral Trauma | 1 | 1995 | 491 | 0.020 |
Why?
|
Mice, SCID | 1 | 2016 | 2626 | 0.020 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2014 | 698 | 0.020 |
Why?
|
Housing | 1 | 1995 | 666 | 0.020 |
Why?
|
Denmark | 1 | 2013 | 759 | 0.020 |
Why?
|
Remission Induction | 1 | 2016 | 2388 | 0.020 |
Why?
|
Phosphorylation | 2 | 2016 | 8297 | 0.020 |
Why?
|
Sweden | 1 | 2013 | 1376 | 0.020 |
Why?
|
Genetic Association Studies | 1 | 2019 | 2717 | 0.020 |
Why?
|
BRCA1 Protein | 1 | 1996 | 1147 | 0.020 |
Why?
|
Dystonia Musculorum Deformans | 1 | 1990 | 158 | 0.020 |
Why?
|
Premenopause | 1 | 1994 | 1038 | 0.020 |
Why?
|
Lipid Metabolism | 1 | 2018 | 1894 | 0.020 |
Why?
|
Databases, Genetic | 1 | 2016 | 1737 | 0.020 |
Why?
|
PTEN Phosphohydrolase | 1 | 2015 | 1113 | 0.020 |
Why?
|
Tissue and Organ Procurement | 1 | 1997 | 943 | 0.020 |
Why?
|
Environment | 1 | 1995 | 1118 | 0.020 |
Why?
|
Chromosome Deletion | 1 | 1993 | 1387 | 0.020 |
Why?
|
Sex Characteristics | 1 | 2019 | 2621 | 0.020 |
Why?
|
Life Style | 1 | 2020 | 3886 | 0.020 |
Why?
|
Jews | 1 | 1990 | 364 | 0.020 |
Why?
|
American Cancer Society | 1 | 2008 | 66 | 0.020 |
Why?
|
Genetic Heterogeneity | 1 | 2011 | 723 | 0.020 |
Why?
|
Home Care Services | 1 | 1994 | 647 | 0.020 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2016 | 3574 | 0.020 |
Why?
|
Health Education | 1 | 1994 | 1049 | 0.020 |
Why?
|
Cluster Analysis | 1 | 1995 | 2697 | 0.020 |
Why?
|
Genetic Testing | 1 | 2001 | 3530 | 0.020 |
Why?
|
Program Evaluation | 1 | 2016 | 2490 | 0.020 |
Why?
|
Health Planning Guidelines | 1 | 2008 | 151 | 0.020 |
Why?
|
Recurrence | 1 | 2019 | 8426 | 0.020 |
Why?
|
Tissue Donors | 1 | 1997 | 2311 | 0.020 |
Why?
|
Phosphoproteins | 1 | 2016 | 2433 | 0.020 |
Why?
|
DNA Repair | 1 | 2016 | 2038 | 0.020 |
Why?
|
Adipose Tissue | 1 | 2019 | 3299 | 0.020 |
Why?
|
Stroke | 1 | 2009 | 9696 | 0.020 |
Why?
|
Regression Analysis | 2 | 1997 | 6353 | 0.020 |
Why?
|
Graft Survival | 1 | 1997 | 3794 | 0.020 |
Why?
|
Consensus | 1 | 2016 | 3099 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2016 | 6293 | 0.020 |
Why?
|
Haplotypes | 1 | 2012 | 2764 | 0.020 |
Why?
|
Population Surveillance | 1 | 2016 | 2606 | 0.020 |
Why?
|
Multicenter Studies as Topic | 1 | 1990 | 1705 | 0.020 |
Why?
|
Marriage | 1 | 1987 | 350 | 0.020 |
Why?
|
Overweight | 1 | 2016 | 2410 | 0.020 |
Why?
|
Insulin Resistance | 1 | 2018 | 3941 | 0.010 |
Why?
|
Genetic Diseases, Inborn | 1 | 1989 | 601 | 0.010 |
Why?
|
Neoplasm Proteins | 1 | 1996 | 3609 | 0.010 |
Why?
|
Disease Susceptibility | 1 | 1991 | 1788 | 0.010 |
Why?
|
Feeding Behavior | 1 | 2016 | 3183 | 0.010 |
Why?
|
Sequence Analysis, DNA | 1 | 2015 | 4711 | 0.010 |
Why?
|
North America | 1 | 2007 | 1276 | 0.010 |
Why?
|
Graft Rejection | 1 | 1997 | 4426 | 0.010 |
Why?
|
Data Collection | 1 | 1993 | 3322 | 0.010 |
Why?
|
Fractures, Bone | 1 | 1995 | 2040 | 0.010 |
Why?
|
Carrier Proteins | 1 | 2016 | 4937 | 0.010 |
Why?
|
Echocardiography, Transesophageal | 1 | 2009 | 1088 | 0.010 |
Why?
|
Animals | 2 | 2016 | 167777 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 1998 | 15225 | 0.010 |
Why?
|
Mothers | 1 | 1993 | 2189 | 0.010 |
Why?
|
DNA Mutational Analysis | 1 | 2010 | 4106 | 0.010 |
Why?
|
Models, Theoretical | 1 | 1994 | 3561 | 0.010 |
Why?
|
Kidney Transplantation | 1 | 1997 | 4217 | 0.010 |
Why?
|
Comorbidity | 1 | 2016 | 10495 | 0.010 |
Why?
|
Kidney | 1 | 1997 | 7016 | 0.010 |
Why?
|
Carcinoma | 1 | 1993 | 2330 | 0.010 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2016 | 5248 | 0.010 |
Why?
|
Polymerase Chain Reaction | 1 | 2010 | 6068 | 0.010 |
Why?
|
Europe | 1 | 2007 | 3420 | 0.010 |
Why?
|
Databases, Factual | 1 | 2016 | 7980 | 0.010 |
Why?
|
Interviews as Topic | 1 | 2008 | 2675 | 0.010 |
Why?
|
Inflammation | 1 | 2020 | 10719 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2016 | 16886 | 0.010 |
Why?
|
Nuclear Proteins | 1 | 2014 | 5787 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 2 | 2015 | 20500 | 0.010 |
Why?
|
Academic Medical Centers | 1 | 2009 | 2751 | 0.010 |
Why?
|
Perception | 1 | 2004 | 1196 | 0.010 |
Why?
|
Glasgow Coma Scale | 1 | 2000 | 579 | 0.010 |
Why?
|
Transcription Factors | 1 | 1996 | 12096 | 0.010 |
Why?
|
Body Surface Area | 1 | 1997 | 197 | 0.010 |
Why?
|
Echocardiography | 1 | 2009 | 4962 | 0.010 |
Why?
|
Electrocardiography | 1 | 2009 | 6363 | 0.010 |
Why?
|
Guideline Adherence | 1 | 2004 | 2215 | 0.010 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2018 | 12076 | 0.010 |
Why?
|
Chromosomes, Human, Pair 13 | 1 | 1993 | 193 | 0.010 |
Why?
|
Attitude of Health Personnel | 1 | 1987 | 3867 | 0.010 |
Why?
|
Polymorphism, Restriction Fragment Length | 1 | 1993 | 763 | 0.010 |
Why?
|
Health Maintenance Organizations | 1 | 1994 | 660 | 0.010 |
Why?
|
Nucleic Acid Hybridization | 1 | 1993 | 1304 | 0.010 |
Why?
|
Drug Therapy | 1 | 1994 | 503 | 0.010 |
Why?
|
Mice | 1 | 2016 | 81107 | 0.010 |
Why?
|
Physicians | 1 | 1987 | 4581 | 0.000 |
Why?
|
DNA, Neoplasm | 1 | 1993 | 1745 | 0.000 |
Why?
|
Exercise Therapy | 1 | 1994 | 919 | 0.000 |
Why?
|
Analysis of Variance | 1 | 1995 | 6233 | 0.000 |
Why?
|
Genes, Recessive | 1 | 1989 | 626 | 0.000 |
Why?
|
Body Weight | 1 | 1997 | 4603 | 0.000 |
Why?
|
Chronic Disease | 1 | 1997 | 9266 | 0.000 |
Why?
|
Severity of Illness Index | 1 | 2000 | 15785 | 0.000 |
Why?
|